Healio
Healio

nr-axSpA Video Perspectives

Healio spoke with experts in nr-AxSpa about treatment options, as well as challenges in managing the disease and areas of unmet need.
Choose a Section
  • Kristi Kuhn, MD, PhD
  • Susan M. Goodman, MD

    • Susan M. Goodman, MD

    In this video, Susan M. Goodman, MD, rheumatologist at Hospital for Special Surgery and professor of medicine at Weill Cornell Medicine, discusses:

    • recent advancements in axial spondyloarthritis treatment, such as drugs that block the IL-17 and IL-12/23 pathways and JAK inhibitors;
    • interesting data related to axSpA presented at ACR 2019;
    • the importance of helping primary care physicians distinguish inflammatory vs. noninflammatory back pain and making the appropriate early referral;
    • the intention of the American College of Rheumatology’s guidance recommending that adults with acute ankylosing spondylitis and nr-axSpA not be switched to a biosimilar;
    • comorbid conditions that play a role in axSpA, such as obesity and depression;
    • the greatest unmet needs in axSpA management, like the need for better recognition.

    Read more about

    secukinumab
    axial spondyloarthritis
    non-radiographic axial spondylarthritis
    janus kinase inhibitor
    You've successfully added to your alerts. You will receive an email when new content is published.

    Click Here to Manage Email Alerts

    We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.